製品の概要

  • 製品名Anti-Cathepsin G antibody
    Cathepsin G 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to Cathepsin G
  • アプリケーション適用あり: WBmore details
  • 種交差性
    交差種: Human
  • 免疫原

    A synthetic peptide based on the propeptide domain and the N terminus of active human cathepsin G

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab49854 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB
  • 追加情報WB: 1/1000 when using colorimetric substrates such as BCIP/NBT, and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 29 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
  • ターゲット情報

    • 機能Serine protease with trypsin- and chymotrypsin-like specificity. Cleaves complement C3. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, antibacterial activity is inhibited by LPS from P.aeruginosa, Z-Gly-Leu-Phe-CH2Cl and phenylmethylsulfonyl fluoride.
    • 配列類似性Belongs to the peptidase S1 family.
      Contains 1 peptidase S1 domain.
    • 細胞内局在Cell surface.
    • Information by UniProt
    • 参照データベース
    • 別名
      • CATG antibody
      • CATG_HUMAN antibody
      • Cathepsin G antibody
      • Cathepsin G precursor antibody
      • CathepsinG antibody
      • CG antibody
      • Ctsg antibody
      • CTSG protein antibody
      • MGC23078 antibody
      see all

    Anti-Cathepsin G antibody 画像

    • All lanes : Anti-Cathepsin G antibody (ab49854) at 1/1000 dilution

      Lane 1 : Human Cathepsin G at 0.01 µg
      Lane 2 : Human Cathepsin G at 0.005 µg
      Lane 3 : Human Cathepsin G at 0.002 µg


      Predicted band size : 29 kDa
      Observed band size : 24,25,29 kDa (why is the actual band size different from the predicted?)

    プロトコール

    Anti-Cathepsin G antibody (ab49854) 使用論文

    This product has been referenced in:
    • Arastu-Kapur S  et al. Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events. Clin Cancer Res 17:2734-43 (2011). WB ; Human . Read more (PubMed: 21364033) »
    • Dabek M  et al. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am J Pathol 175:207-14 (2009). WB ; Human . Read more (PubMed: 19528350) »

    See all 2 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab49854.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"